Studies from Birjand University of Medical Sciences in the Area of Multiple Myeloma Described (Bimetallic S. Pachycarpa@ag-doped Zno Alloy Nanoparticles Unveil Therapeutic Promise: Revolutionizing Multiple Myeloma Treatment).

Předmět:	MULTIPLE myeloma BLOOD protein disorders ZINC oxide NANOPARTICLES BLOOD diseases
Zdroj:	Hematology Week; 2024, p1271-1271, 1p
Abstrakt:	A study conducted by researchers at Birjand University of Medical Sciences in Iran has explored the potential therapeutic properties of bimetallic S. pachycarpa@ag-doped ZnO nanoparticles for the treatment of multiple myeloma. The researchers used green synthesis to create the nanoparticles and conducted tests on U266B1 cells to evaluate their toxicity and impact on cell viability. The results showed that the nanoparticles had a concentration-dependent effect on cell viability and increased the expression level of the P53 gene. While further studies are needed to understand the mechanism of action, the findings suggest that S. pachycarpa@ag-doped ZnO nanoparticles could be a promising avenue for multiple myeloma treatment. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu